Recent and ongoing clinical trials for treating colorectal cancer

Mary F. Mulcahy, Al B. Benson*

*Corresponding author for this work

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Colorectal cancer is one of the most common cancers worldwide. Through well-designed clinical trials, advances have been made in the treatment of localised and advanced colorectal cancer. It has been established that 6 months of 5-fluorouracil-based chemotherapy will improve overall survival in patients with stage III colon cancer. The role of adjuvant chemotherapy in stage II colon cancer remains an unresolved issue. Recent studies have demonstrated an improved survival with the addition of irinotecan to 5-fluorouracil and leucovorin for the treatment of advanced colorectal cancer. Immunotherapy, molecular targeted therapy and liver-directed therapy, in addition to new chemotherapy combinations, are all being evaluated for the treatment of localised and advanced colorectal cancer. Ongoing and proposed studies are incorporating the identification of genetic and molecular abnormalities, which may provide prognostic information as well as direct treatment decisions.

Original languageEnglish (US)
Pages (from-to)871-880
Number of pages10
JournalExpert Opinion on Investigational Drugs
Volume11
Issue number6
DOIs
StatePublished - Jun 22 2002

Keywords

  • Adjuvant therapy
  • Clinical trials
  • Colon cancer
  • Rectal cancer

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Recent and ongoing clinical trials for treating colorectal cancer'. Together they form a unique fingerprint.

  • Cite this